Business Description
Avrobio Inc
NAICS : 325414
SIC : 2836
ISIN : US05455M1009
Description
Avrobio Inc is a clinical-stage gene therapy company. The company is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single-dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the treatment of Gaucher disease type 1; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-03 for the treatment of Pompe disease.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 111.64 | |||||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.07 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 21.4 | |||||
| 3-Year EPS without NRI Growth Rate | 23 | |||||
| 3-Year FCF Growth Rate | 19.9 | |||||
| 3-Year Book Growth Rate | -29.7 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.86 | |||||
| 9-Day RSI | 33.9 | |||||
| 14-Day RSI | 37.9 | |||||
| 6-1 Month Momentum % | -17.95 | |||||
| 12-1 Month Momentum % | 35.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 15.78 | |||||
| Quick Ratio | 15.78 | |||||
| Cash Ratio | 15.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.4 | |||||
| Shareholder Yield % | 17.55 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | 13.57 | |||||
| ROA % | 11.42 | |||||
| ROIC % | -850.53 | |||||
| ROC (Joel Greenblatt) % | 393.8 | |||||
| ROCE % | 12.55 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 4.44 | |||||
| Price-to-Owner-Earnings | 7.6 | |||||
| PB Ratio | 0.57 | |||||
| Price-to-Tangible-Book | 0.57 | |||||
| EV-to-EBIT | -3.52 | |||||
| EV-to-EBITDA | -3.35 | |||||
| EV-to-FCF | 0.67 | |||||
| Price-to-Net-Current-Asset-Value | 0.57 | |||||
| Price-to-Net-Cash | 0.59 | |||||
| Earnings Yield (Greenblatt) % | -28.41 | |||||
| FCF Yield % | -117.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AVRO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Avrobio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0.27 | ||
| Beta | 1.39 | ||
| Volatility % | 70.17 | ||
| 14-Day RSI | 37.9 | ||
| 14-Day ATR ($) | 0.049362 | ||
| 20-Day SMA ($) | 1.25775 | ||
| 12-1 Month Momentum % | 35.54 | ||
| 52-Week Range ($) | 0.57 - 1.7 | ||
| Shares Outstanding (Mil) | 44.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Avrobio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Avrobio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Avrobio Inc Frequently Asked Questions
What is Avrobio Inc(AVRO)'s stock price today?
The current price of AVRO is $1.21. The 52 week high of AVRO is $1.70 and 52 week low is $0.57.
When is next earnings date of Avrobio Inc(AVRO)?
The next earnings date of Avrobio Inc(AVRO) is 2024-05-10 Est..
Does Avrobio Inc(AVRO) pay dividends? If so, how much?
Avrobio Inc(AVRO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers